biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > How Low Can It Go?

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton May 06, 2021 10:52am

107 Views

Post# 33140419

RE:RE:RE:RE:RE:How Low Can It Go?

aarcor, go look at my historical posts. I have always touted xB3, not Bioasis. It's a distinction missed by you and the anti-everything cadre. The fact is, Bioasis people have failed and xB3 has not.

I believe that DrDR has had only a 10-month run as a funded CEO and, finally, Bioais is doing something, despite the effects of the pandemic..

You and others are engaged in superficial assessments. Always have been.

The solution is easy for all of you. You know what it is. Funny how all those shares dumped out of frustration, anxiety and anger are always bought up by the buyers lying in wait for them.

jd

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks